Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Huge bid at 6.5 cents.

<< Previous

Bullboard Posts

Next >>

Post by bealerton Sep 03, 2024 2:47pm

462 Views

Post# 36206661

Huge bid at 6.5 cents.

Looks a lot better than earlier.

Maybe somebody has the inside track better than we do if they are bidding for 680 thousand at 6.5.

We understand there might be an update or press release soon. What does this actually mean?

Without definition, it means little to nothing, especially with SBM

Anyway, I hope we can all come out of this stinkhole alive with something to show for our many, many, years of foolish waiting.

BeAlert

Enjoy your September as the weather where I live is so pleasant now.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant